Mankind Pharma has tied up with diagnostics equipment major Roche Diagnostics India to market the latter’s new diabetes monitoring device Accu-Check Go.
Cricketer Wasim Akram is Roche’s brand ambassador
NEW DELHI: Mankind Pharma has tied up with diagnostics equipment major Roche Diagnostics India to market the latter’s new diabetes monitoring device Accu-Check Go.
Pakistani cricketing legend Wasim Akram, who wants to promote diabetes awareness among the school children in the country, is Roche’s brand ambassador for its another product Accu-Chek Active, currently available in the market for Rs 1,790.
Accu-Check Go is an upgraded version of Accu-Chek Active and will be available in market for Rs 1,990. It comes with disposable capillary action test strips to prevent blood-related infections like HIV/AIDS, etc. Each test would cost a patient Rs 28.
However, unlike the previous blood glucose monitoring equipment which is directly sold over the counter, Accu-Check Go will be promoted through doctors by Mankind in 500 towns across India.
Mankind hopes to add about Rs200 crore to its revenues in the next five years with this new deal.
“In the first year itself, the new business would contribute Rs20 crore to our revenues while in the next five years we expect a turnover of Rs200 crore through this agreement,” said R C Juneja, managing director of Mankind Pharma.
“The focus of this venture is to communicate the importance of diabetes management and at the same time increase the availability of efficient tools for people with diabetes and their caregivers,” said Juneja.
Mankind will also hold road shows and about 2000 camps to create awareness, especially in the rural areas and schools. Mankind is also planning to step out into newer markets, including the US, to become a Rs 1,000 crore company over the next three years. The company has plans to set up marketing offices in Nepal and Burma.
Currently, the company operates in the domestic drug market with 44 brands. “We would soon tap South Asian market and Russia which offer a huge growth potential. The company has already applied for registering 20 products in these countries,” Juneja said.
p_vineeta@dnaindia.net
){kind=small}
){kind=small}
){kind=small}
){kind=small}
){kind=small}
){kind=small}
){kind=small}
){kind=small}
){kind=small}
){kind=small}
){kind=small}
){kind=small}
){kind=small}
){kind=small}
){kind=small}
){kind=small}
){kind=small}
){kind=small}
){kind=small}
){kind=small}
){kind=small}
){kind=small}
)
){kind=small}
){kind=small}
)
)
)
)
)
){kind=small}
){kind=small}
){kind=small}
){kind=small}
){kind=small}